MannKind Corp. Equity-NMS: MNKD

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$4.66

52W high :

$4.86

1Y :

-40.19%

5Y :

-42.22%

EPS(TTM): :

-0.3839

Shares O/S :

263.2 M

Market cap :

1.27 B

What is the share price of MannKind Corp. today?

MannKind Corp. (MNKD) share price as of October 11, 2022, is $3.02. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of MannKind Corp.?

Yes, Indian Investors can invest in the MannKind Corp. (MNKD) Share by opening an international trading account with Angel One.

How can I purchase MannKind Corp. shares in India?

Purchasing MannKind Corp. (MNKD) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying MannKind Corp. (MNKD) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of MannKind Corp.?

Yes, you can purchase fractional shares of MannKind Corp. (MNKD) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of MannKind Corp.?

The market capitalization of MannKind Corp. on December 3, 2022, is $762.75 M.

In which sector MannKind Corp. belongs?

MannKind Corp. operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in MannKind Corp. stocks?

In order to invest in MannKind Corp. (MNKD) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

MannKind Corporation is a biopharmaceutical company. The Company is focused on the development and commercialization of inhaled therapeutic products for diabetes and orphan lung diseases, such as pulmonary arterial hypertension. The Company’s lead product is Afrezza Inhalation Powder, which is an inhaled insulin indicated to improve glycemic control in adults with diabetes. Afrezza consists of a dry powder formulation of human insulin delivered from a small portable inhaler. AFREZZA utilizes its Technosphere formulation technology. The Technosphere is a drug delivery platform that allow the oral inhalation of a range of therapeutics.